Tyler Melton

Tyler Melton serves as the Chief Executive Officer of Corveus Medical, a company he established following his participation in the TMCi Biodesign program. He holds an MBA from Rice University and has a strong foundation in biomedical engineering. Prior to founding Corveus Medical, Melton worked in consulting for five years, which provided him with extensive experience in the healthcare sector. His entrepreneurial journey includes participation in prestigious programs such as Y Combinator in January 2022 and MedTech Innovator in June 2022. In March 2023, he received an NSF SBIR – Phase 1 grant, underscoring his innovative approach in the medical field. Additionally, Melton achieved significant recognition by placing first at the Texas A&M New Ventures Competition, where he was awarded $35,000.